HSTC

HST Global, Inc. [HSTC] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

HSTC Stock Summary

Top 10 Correlated Stocks

HSTC

In the News

HSTC Financial details

Company Rating
-
Market Cap
5.88M
Income
-148.63K
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
31 Mar 2023
P/E
-12.66
Forward P/E
-
PEG
-58.24
P/S
-
P/B
-3.36
P/C
-
P/FCF
-93.25
Quick Ratio
-
Current Ratio
-
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.03
EPS next Y
-
EPS next Q
-
EPS this Y
1.09%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
2.94%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-7372%
ROE
29%
ROC
0.25%
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.1-1.15
52W High
-
52W Low
-
RSI
22
Rel Volume
2.8
Avg Volume
249
Volume
696
Perf Week
0%
Perf Month
0%
Perf Quarter
-99.98%
Perf Half Y
-99.98%
-
-
-
-
Beta
-0.992
-
-
Volatility
0%, 0%
Prev Close
0%
Price
0.0002
Change
0%

Something similar

Top by Market Cap
LLY.DE
LLY.SW
GOOG
0YXG.L
LLY
Same Sector
SLDB
GTBIF
BYSI
LSFP
MLND
Top Correlated Stocks
MICR
SOFO
ABMT
ABTI
ACBM
Similar Market Cap
8347.HK
DIVA
EARS
WHLRD
SDX.L

Company Profile

Healthcare Biotechnology
  • Volume Average 249
  • Market Capitalization 5.88M
  • CEO Mr. Ronald R. Howell
  • Headquarters Hampton,VA,US
  • IPO Date 2002-06-24
  • Website https://www.hstglobal.com

HST Global, Inc., an integrated health and wellness biotechnology company, develops and/or acquires a network of wellness centers for the homeopathic and alternative treatment of late stage cancer worldwide. It also focuses on the homeopathic and alternative product candidates that are undergoing or have already completed clinical testing for the treatment of late stage cancers and other life-threatening diseases. HST Global, Inc. is headquartered in Hampton, Virginia.